• Benign Prostatic Hyperplasia
  • Hormone Therapy
  • Genomic Testing
  • Next-Generation Imaging
  • UTUC
  • OAB and Incontinence
  • Genitourinary Cancers
  • Kidney Cancer
  • Men's Health
  • Pediatrics
  • Female Urology
  • Sexual Dysfunction
  • Kidney Stones
  • Urologic Surgery
  • Bladder Cancer
  • Benign Conditions
  • Prostate Cancer

Investigators analyze patterns of treatment preferences in patients with OAB


“Our goal was to educate these patients thoroughly on the risks and benefits of each of these therapies, and try to understand what guides their choice of third line therapy based on their lifestyle and what suits them,” says Anjali Kapur, MD.

In this video, Anjali Kapur, MD, and Jason Kim, MD, discuss the background and findings of the study, “Patient preference of third line therapy for overactive bladder,” which will be presented at the Society of Women in Urology Annual Clinical Mentoring Conference. Kapur is a PGY-4 resident and Kim is an associate professor of urology, director of the Women’s Pelvic Health and Continence Center, and urology residency program director at Stony Brook Medicine in East Setauket, New York.

Related Videos
Mature woman with her doctor | Image Credit: © pucko_ns - stock.adobe.com
Jaleh Fallah, MD, answers a question during a Zoom video interview
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
doctor showing a patient some information on a digital tablet | Image Credit: © bongkarn - stock.adobe.com
Blurred interior of hospital | Image Credit: © jakkapan - stock.adobe.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.